Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Advertising Standards Authority criticised for flat-faced dog advert
British bulldogs can suffer serious health problems, including breathing difficulties.
BVA’s senior VP Malcolm Morley called the ad ‘extraordinary’.

The senior vice-president of the British Veterinary Association (BVA) has criticised the Advertising Standards Authority (ASA) after it used a flat-faced dog in its latest advertising campaign.

Dr Malcolm Morley called the advertisement, parodying Churchill Insurance’s bulldog imagery, ‘extraordinary’ for its use of the brachycephalic breed, which is known for its serious health problems.

The ASA advertisement depicts a bulldog riding a skateboard, in a reference to Churchill Insurance’s recent campaign. The British bulldog has long featured as the insurance company’s mascot, since an employee competition in 1994.

However, in a post on social media site X, Dr Morley has questioned the ASA’s decision to include the dog in its own advertisement. He suggested that using flat-faced dogs in advertising has contributed to increased demand for unhealthy, brachycephalic dogs.

In the thread, Dr Morley pushed for ‘respected influential organisations’ to consider animal welfare, and use images of appropriate and healthy animals in their advertising. He expressed his hope that the ASA would remove the advertisement.

The dispute comes as the BVA continues its ‘Breed to Breathe’ campaign, calling for the improvement of the welfare of brachycephalic dog breeds, such as British bulldogs, French bulldogs and pugs. These flat-faced breeds can suffer serious health and welfare issues, including breathing problems, eye disease and dental problems.

The BVA encourages supporters to ask companies to avoid using brachycephalic breeds in their advertising and marketing.

However the ASA has said that, while they share Dr Morley’s concerns about dog welfare and unhealthy breeding practices, they do not agree that its advertisement promotes the bulldog or brachycephalic breeds.

Matt Wilson, ASA media and public affairs manager, said: “Our ad is one in a series in which we have borrowed famous slogans from several well-known campaigns. In this instance, we’ve used the 'oh yes' strapline from Churchill Insurance and we’ve also featured the British bulldog synonymous with the brand.

“Our ad does not, in our view, encourage or condone cruel breeding practices or encourage/stimulate greater demand for the breed. It is designed to raise awareness of the ASA and to remind people that we regulate UK ads across media.
 
“The BVA has issued clear guidance in this area. We are supportive of it and signpost/link to it in our own advice. We do not consider that our ad runs contrary to it.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.